<tt id="6hsgl"><pre id="6hsgl"><pre id="6hsgl"></pre></pre></tt>
          <nav id="6hsgl"><th id="6hsgl"></th></nav>
          国产免费网站看v片元遮挡,一亚洲一区二区中文字幕,波多野结衣一区二区免费视频,天天色综网,久久综合给合久久狠狠狠,男人的天堂av一二三区,午夜福利看片在线观看,亚洲中文字幕在线无码一区二区
          USEUROPEAFRICAASIA 中文雙語Fran?ais
          China
          Home / China / China

          Interest in TCM growing globally

          By Shan Juan | China Daily | Updated: 2013-03-27 07:14

          Chinese mainland accounts for 2% of herbal medicine sales worldwide

          While some Chinese scholars propose abolishing traditional Chinese medicine, foreign pharmaceutical institutions and industries are pursuing them.

          More than 100 countries and regions around the world have set up TCM institutions, with the United States, Europe, Japan and South Korea investing heavily in related research and medication development, industry, analyses show.

          The UK-based pharmaceutical company GlaxoSmithKline PLC announced its first TCM medication research and development program, which targets not just the Chinese market, but the global one as well.

          "TCM is a well-established medical science based on thousands of years of clinical practices. It shows great promise treating complicated conditions that the single-target Western medicine has failed to handle," said Zang Jingwu, senior vice-president and head of GlaxoSmithKline's R&D in China.

          "Our priority is to transform TCM from an experience-based practice to evidence-based medicines through innovation and differentiation," he said.

          Currently, a 10-person team in Shanghai is in charge of the program, with a medication candidate for skin disease in the works.

          Zang, a US-trained neurologist, said TCM is more of a multi-target therapeutical approach, which might work to treat complex conditions.

          He said an example of this is ginkgo biloba leaf extract, approved in Germany, which, according to China's pharmacopeia, is TCM in essence. Globally, ginkgo biloba leaf extract is widely used to treat dizziness and ringing in the ears.

          Industry insiders call such products "exotic TCM". In ancient TCM works, ginkgo is known for restoring consciousness.

          "That is similar to our approach in TCM R&D," he said. He referred to skin diseases for which medications can demonstrate more evidence of effectiveness as a top candidate for TCM. Other areas of research that also show great promise include stomach and intestinal diseases and supplementary treatments for cancer, he added.

          However, given that the culture and ideology of TCM is different from that of Western medicine, great innovation is required to integrate the two sciences, he said.

          "In fact, many in Western medicine circles have recognized the importance of TCM, but the problem is how to prove and develop that," said Huang Jianyin, deputy secretary-general of the World Federation of Chinese Medicine Societies.

          TCM is developed through empirical testing and refinement of herbal mixtures and relies on clinical experience, and many in the West don't trust that, he said. TCM, particularly herbal products, are largely available in the US and Europe, but questions like how to prove their effectiveness in the context of Western medicine and how to best use them remain unanswered, Zang added.

          Zhang Lingping, director of the international cooperation department of the Beijing University of Chinese Medicine, welcomed the emerging trend.

          "Their increasing interest shows Western medicine circles have begun to learn about the time-honored medical science, which originated in China," she said. Zhang said traditionally, Western medicines have been highly targeted and such a method doesn't seem to work well for complex diseases.

          "They are beginning to closely look at TCM, which highlights a natural and comprehensive manner in healing," she said.

          The university also had partnerships with foreign academic institutions in TCM research focusing on cancer and cardio-cerebrovascular diseases.

          A better approach for TCM development is to enhance its dosage and stability, she said.

          "It's more feasible and practical for them to improve the techniques during the TCM production, which the multinational pharmaceutical giants are better at," she said.

          But that might also pose a challenge for domestic TCM industries, she acknowledged.

          Of the global herbal medicine sales volume, the Chinese mainland accounted for only 2 percent, industry analyses show. Japan has the share of the market at 90 percent.

          Mao Zedong once expected TCM and Chinese cuisine would be China's two major contributions to the world, said Huang. "He wouldn't have imagined the tough situation today."

          shanjuan@chinadaily.com.cn

          Editor's picks
          Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
          License for publishing multimedia online 0108263

          Registration Number: 130349
          FOLLOW US
          主站蜘蛛池模板: 潘金莲高清dvd碟片| 国产老熟女视频一区二区| 色综合中文综合网| 99国产成+人+综合+亚洲欧美| 日韩国产精品区一区二区| 90后极品粉嫩小泬20p | 亚洲精品天堂在线观看| 久久精品国产亚洲精品2020| 国产主播一区二区三区| 亚洲色拍拍噜噜噜最新网站| 99国产精品久久久久久久成人热 | 377P欧洲日本亚洲大胆| 色综合AV综合无码综合网站| 120秒试看无码体验区| 国产精品久久久久久久久久直播| 国产99视频精品免费视频36| 一区二区三区av天堂| 国产内射一级一片内射高清视频 | 国产精品自拍中文字幕| 无码专区视频精品老司机 | 风韵丰满熟妇啪啪区老老熟妇| 亚洲码欧美码一区二区三区| 亚洲成在人线AⅤ中文字幕| 视频一区二区三区四区五区| 亚洲AV国产福利精品在现观看| 日日碰狠狠躁久久躁96avv| 2021国产成人精品国产| 亚洲欧美电影在线一区二区| 日本中文字幕一区二区三| 国产精品一二三区蜜臀av| 性XXXX视频播放免费直播| 忘忧草在线社区www中国中文 | 强d乱码中文字幕熟女1000部| 久久精品国产精品亚洲| 伊人色综合九久久天天蜜桃| 亚洲欧洲日韩国内精品| 亚洲欧美日韩中文字幕网址| 久久精品熟妇丰满人妻久久| 无码专区一va亚洲v专区在线| 久久精品日日躁夜夜躁| 公天天吃我奶躁我的在|